申请人:UCHREZHDENIE KHIMICHESKIJJ FAKUL'TET GOSUDARSTVENNOE UCHEBNO-NAUCHNOE
公开号:US20130109861A1
公开(公告)日:2013-05-02
The invention relates to the field of organic and medicinal chemistry, and molecular biology, and concerns a method for the preparation of a new class of telomerase-inhibiting compounds, which can be utilized for studying telomerases and catalytic sub-units of telomerases, and reverse transcriptases, and foe studying and treating neoplastic and viral diseases. Telomerase-inhibiting coordination compounds of derivatives of imidazol-4-one are characterized by general formula
本发明涉及有机化学、药物化学和分子生物学领域,涉及一种制备新型端粒酶抑制剂化合物的方法,可用于研究端粒酶和催化亚单位,以及反转录酶,用于研究和治疗肿瘤和病毒性疾病。咪唑-4-酮衍生物的端粒酶抑制配位化合物的一般式如下: